NASDAQ$COO
The Cooper Companies Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Reported a revenue increase of 9% year-over-year, reaching $931.6 million, with strong performance in contact lenses and fertility segments and non-GAAP EPS increased by 18% to $0.85.
CooperCompanies announced strong Q1 2024 results with record quarterly revenues of $931.6 million, a 9% increase year-over-year. CooperVision revenue grew by 7% and CooperSurgical revenue grew by 12%. The company's non-GAAP EPS increased by 18% to $0.85.
- Revenue increased 9% year-over-year to $931.6 million.
- CooperVision (CVI) revenue up 7% to $621.5 million.
- CooperSurgical (CSI) revenue up 12% to $310.1 million.
- Non-GAAP diluted EPS of $0.85, up $0.12 or 18% from last year's first quarter.
Headline financials
Revenue & EPS history
Cooper · Revenue · Quarterly
$932M
Revenue by segment
Cooper · $304M total across 2 segments · Q4 2023
- Office and Surgical$183M+2.9%60.1%
- Fertility$121M+11.8%39.9%
Forward guidance
The Company raised its fiscal year 2024 financial guidance.
Tailwinds
- Fiscal 2024 total revenue of $3,847 - $3,897 million (organic growth of 7% to 8%)
- CVI revenue of $2,573 - $2,604 million (organic growth of 8% to 9%)
- CSI revenue of $1,274 - $1,293 million (organic growth of 5% to 7%)
- Fiscal 2024 non-GAAP diluted EPS of $3.50 - $3.58
- Momentum is excellent with capacity expansion progressing well and demand remaining very healthy.
Headwinds
- Guidance excludes amortization and impairment of intangible assets, and other exceptional or unusual income or gains and charges or expenses including acquisition and integration costs
- inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses
- impact of international conflicts, such as Russia's invasion of Ukraine
- Compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information
- market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
+0.6%
Avg return
Earnings day
-0.3%
Avg return
5 days after
-0.1%
Avg return
30 days after
52%
36 / 69 earnings
Positive
+12.1%
Q3 2024
Best reaction
-12.8%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | +10.3% | +9.7% | — | |
| Q1 2026 | -4.6% | -8.0% | -12.5% | |
| Q4 2025 | -4.3% | +4.8% | +5.3% | |
| Q3 2025 | -12.8% | -11.8% | -8.9% | |
| Q2 2025 | +0.0% | -0.3% | +3.6% | |
| Q1 2025 | -6.6% | -13.1% | -18.9% | |
| Q4 2024 | -6.0% | -5.6% | -12.6% | |
| Q3 2024 | +12.1% | +12.1% | +16.4% | |
| Q2 2024 | +3.5% | +3.8% | -4.2% | |
| Q1 2024 | +8.1% | +7.3% | +7.4% | |
| Q4 2023 | -2.2% | -0.7% | +6.8% | |
| Q3 2023 | -2.1% | -3.5% | -15.9% | |
| Q2 2023 | -4.0% | -5.1% | +3.2% | |
| Q1 2023 | +8.7% | +3.9% | +15.4% | |
| Q4 2022 | -1.6% | +4.8% | +9.7% | |
| Q3 2022 | +4.1% | +2.5% | -8.5% | |
| Q2 2022 | -0.3% | +1.3% | -7.2% | |
| Q1 2022 | +2.1% | -8.5% | +3.1% | |
| Q4 2021 | +4.8% | +8.7% | +12.2% | |
| Q3 2021 | +1.1% | -0.7% | -7.6% | |
| Q2 2021 | -0.7% | -3.2% | +6.0% | |
| Q1 2021 | +1.8% | +0.3% | +1.1% | |
| Q4 2020 | +3.3% | +3.3% | +8.6% | |
| Q3 2020 | +2.0% | +0.3% | +5.7% | |
| Q2 2020 | -0.2% | -5.0% | -9.1% | |
| Q1 2020 | -1.3% | -0.9% | -17.3% | |
| Q4 2019 | -1.6% | -2.4% | +3.3% | |
| Q3 2019 | -3.5% | -6.7% | -8.3% | |
| Q2 2019 | +4.5% | +9.0% | +18.2% | |
| Q1 2019 | -1.8% | +0.1% | +1.0% | |
| Q4 2018 | -11.6% | -7.3% | -10.4% | |
| Q3 2018 | -3.7% | -3.4% | +4.3% | |
| Q2 2018 | +1.4% | -0.4% | +6.0% | |
| Q1 2018 | +2.1% | -3.8% | -11.5% | |
| Q4 2017 | -3.2% | -1.9% | -1.5% | |
| Q3 2017 | -4.0% | -2.5% | -3.7% | |
| Q2 2017 | +8.9% | +10.5% | +9.4% | |
| Q1 2017 | -3.1% | -3.6% | -0.4% | |
| Q4 2016 | +1.3% | +4.1% | +5.2% | |
| Q3 2016 | +0.0% | +1.3% | -3.6% | |
| Q2 2016 | -0.1% | -0.4% | +7.1% | |
| Q1 2016 | +6.4% | — | — | |
| Q4 2015 | -12.8% | — | — | |
| Q3 2015 | -7.1% | — | — | |
| Q2 2015 | -5.1% | — | — | |
| Q1 2015 | +9.7% | — | — | |
| Q4 2014 | -4.4% | — | — | |
| Q3 2014 | +0.7% | — | — | |
| Q2 2014 | +1.7% | — | — | |
| Q1 2014 | +4.3% | — | — | |
| Q4 2013 | -4.6% | — | — | |
| Q3 2013 | -1.8% | — | — | |
| Q2 2013 | +8.1% | — | — | |
| Q1 2013 | +2.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.3% | — | — | |
| Q2 2012 | -4.1% | — | — | |
| Q1 2012 | +2.8% | — | — | |
| Q4 2008 | +2.8% | — | — | |
| Q4 2011 | +2.8% | — | — | |
| Q3 2011 | -1.8% | — | — | |
| Q2 2011 | +1.4% | — | — | |
| Q2 2010 | +1.4% | — | — | |
| Q1 2010 | +8.9% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q3 2010 | +5.8% | — | — | |
| Q4 2009 | +5.8% | — | — | |
| Q3 2009 | +5.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro